Insulin rectal (Oramed Pharmaceuticals)

N/A

Report date: 2022/02/11 17:32:51

Base Information

Drug NameInsulin rectal (Oramed Pharmaceuticals)
Drug Alias NameORMD0802Insulin human (Oramed)Insulin suppositoryORMD 0802ORMD-0802
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOramed Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOramed Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 1

Other Information

ATC CodeA10AB01A10AC01A10AD01 +[5
Related LinksN/A